Allogeneic Therapy Segment Held Largest Share of South and Central America Cell therapy Market in 2019
According to our new market research study on “South and Central America Cell therapy Market to 2027 - Regional Analysis and Forecast - by ingredient type, indication, and forms,” the market is expected to reach US$ 415.8 million by 2027 from US$ 271.9 million in 2019; it is estimated to grow at a CAGR of 5.5% from 2020 to 2027. The report provides trends prevailing in the South and Central America Cell therapy market, and drivers and restraints pertaining to the market growth.
The South and Central America Cell therapy market based on therapy type is segmented into Allogeneic, Autologous. In 2019, the allogeneic segment accounted for the largest share of the South and Central America Cell therapy market. The growth of the market for this segment is attributed to increasing Number of product launch to accelerate the overall product demand for stem therapy using allogeneic stem cell therapeutics. However, the autologous segment is likely register the highest CAGR in the market during the forecast period.
The growth of the South and Central America Cell therapy market is mainly attributed to Increasing Prevalence of Chronic Diseases, Rising Adoption of Regenerative Medicines and Increasing Number of Approvals for Cell-Based Therapies. However, high costs of cell therapy manufacturing is the major factor hindering the market growth in South and Central America.
A few of the leading companies operating in the South and Central America Cell therapy market are NuVasive, Inc., Smith & Nephew, Bristol-Myers Squibb Company, Cells for Cells and others.
The report segments South and Central America Cell therapy market as follows:
South and Central America Cell therapy Market - By Therapy Type
South and Central America Cell therapy Market - By Product
South and Central America Cell therapy Market - By Technology
South and Central America Cell therapy Market - By Application
South and Central America Cell therapy Market - By End user
South and Central America Cell therapy Market - By Country
Reasons to Buy
It provides understanding of the South and Central America, cell therapy market landscape and identifies cell therapy market segments that are most likely to guarantee a strong return.It guides
Stay ahead of the race by comprehending the ever-changing competitive landscape for the South and Central America cell therapy market.It helps
Efficiently plan merger and acquisition, and partnership deals in the cell therapy market by identifying market segments with the most promising probable sales.
It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cell therapy market performance of various segments pertaining to the South and Central America cell therapy market.
It provides cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.
According to our new market research study on “South and Central America Cell therapy Market to 2027 - Regional Analysis and Forecast - by ingredient type, indication, and forms,” the market is expected to reach US$ 415.8 million by 2027 from US$ 271.9 million in 2019; it is estimated to grow at a CAGR of 5.5% from 2020 to 2027. The report provides trends prevailing in the South and Central America Cell therapy market, and drivers and restraints pertaining to the market growth.
The South and Central America Cell therapy market based on therapy type is segmented into Allogeneic, Autologous. In 2019, the allogeneic segment accounted for the largest share of the South and Central America Cell therapy market. The growth of the market for this segment is attributed to increasing Number of product launch to accelerate the overall product demand for stem therapy using allogeneic stem cell therapeutics. However, the autologous segment is likely register the highest CAGR in the market during the forecast period.
The growth of the South and Central America Cell therapy market is mainly attributed to Increasing Prevalence of Chronic Diseases, Rising Adoption of Regenerative Medicines and Increasing Number of Approvals for Cell-Based Therapies. However, high costs of cell therapy manufacturing is the major factor hindering the market growth in South and Central America.
A few of the leading companies operating in the South and Central America Cell therapy market are NuVasive, Inc., Smith & Nephew, Bristol-Myers Squibb Company, Cells for Cells and others.
The report segments South and Central America Cell therapy market as follows:
South and Central America Cell therapy Market - By Therapy Type
- Allogeneic
- Autologous
South and Central America Cell therapy Market - By Product
- Consumables
- Equipment
- Systems and Software
South and Central America Cell therapy Market - By Technology
- Viral Vector Technology
- Genome Editing Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Cell Plasticity Technology
- Three-dimensional Technology
South and Central America Cell therapy Market - By Application
- Oncology
- Cardiovascular
- Orthopedic
- Wound Management
- Other Applications
South and Central America Cell therapy Market - By End user
- Research Institutes
- Hospitals
- Others
South and Central America Cell therapy Market - By Country
- South and Central America
- Brazil
- Argentina
Reasons to Buy
It provides understanding of the South and Central America, cell therapy market landscape and identifies cell therapy market segments that are most likely to guarantee a strong return.It guides
Stay ahead of the race by comprehending the ever-changing competitive landscape for the South and Central America cell therapy market.It helps
Efficiently plan merger and acquisition, and partnership deals in the cell therapy market by identifying market segments with the most promising probable sales.
It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cell therapy market performance of various segments pertaining to the South and Central America cell therapy market.
It provides cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.
Table of Contents
1. Introduction
3. Research Methodology
4. South and Central America Cell Therapy Market - Market Landscape
5. South and Central America Cell Therapy Market - Key Market Dynamics
6. Cell Therapy Market - South and Central America Analysis
7. South and Central America Cell Therapy Market Analysis - By Therapy Type
8. South and Central America Cell Therapy Market Analysis - By Product
9. South and Central America Cell Therapy Market Analysis - By Technology
10. South and Central America cell therapy market Analysis - By Application
11. South and Central America cell therapy market Analysis - By End User
12. South and Central America Cell Therapy Market Analysis And Forecasts To 2027 - Regional Analysis
13. Impact of COVID-19 Pandemic on South and Central America Cell Therapy Market
14. Company Profiles
15. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- NuVasive, Inc.
- Smith & Nephew
- Bristol-Myers Squibb Company
- Cells for Cells
![T Cell Therapy Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Modality, Therapy Type [CAR T-cell Therapy and T-cell Receptor-based], Indication, and Geography - Product Image](http://www.researchandmarkets.com/product_images/12573/12573998_60px_jpg/market_research_report.jpg)
